The market capitalization of AIM stocks reached £103bn as of 13th January 2023 compared to the 15th of December 2022. Among the top YTD winners, there were Genincode Plc (+100% YTD on approval of California State licensing approval and CLIA certification of its Irvine laboratory in California, enabling the provision of its products for the risk assessment of CVD to patients across 49 states in the US), Quantum Blockchain Technologies (86.7% on successful legal claim resolution), musicMagpie (66. ....
18 Jan 2023
LSE AIM - Market Screener
Trident Royalties Plc (TRR:LON), 34.5 | Renalytix Plc (RENX:LON), 30.0 | Bidstack Group Plc (BIDS:LON), 0 | Savannah Energy Plc (SAVE:LON), 26.4
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LSE AIM - Market Screener
Trident Royalties Plc (TRR:LON), 34.5 | Renalytix Plc (RENX:LON), 30.0 | Bidstack Group Plc (BIDS:LON), 0 | Savannah Energy Plc (SAVE:LON), 26.4
- Published:
18 Jan 2023 -
Author:
Marina Alekseenkova -
Pages:
9
The market capitalization of AIM stocks reached £103bn as of 13th January 2023 compared to the 15th of December 2022. Among the top YTD winners, there were Genincode Plc (+100% YTD on approval of California State licensing approval and CLIA certification of its Irvine laboratory in California, enabling the provision of its products for the risk assessment of CVD to patients across 49 states in the US), Quantum Blockchain Technologies (86.7% on successful legal claim resolution), musicMagpie (66. ....